dpp 4 inhibitors and glp 1 agonists together The pharmacology of DPP-4 is divided into primary Insights into the Roles of
Description
Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L

The glucagon-like Peptide-1 analog exenatide increases blood glucose clearance, lactate clearance, and heart rate in comatose patients after out-of-hospital cardiac arrest

Cardioprotective and vasodilatory actions of glucagonlike peptide 1 receptor are mediated through both glucagonlike peptide 1 receptordependent and independent pathways

doi: 10.1016/j.jacc.2022.11.005 2 MarxNHusainMLehrkeMVermaSSattarN
Author: Jason Kritzer and James Cullen

2020;141:e139596
